Skip to main content

Klinger Shannon Thyme's Form 4 filing

Moderna, Inc. (MRNA) · filed Mar 3, 2026

Accession no.
0001682852-26-000040
Filed
Mar 3, 2026
Trade date
Feb 27-Mar 2, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 7 derivative transactions. Open-market sales total $726.0K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klinger Shannon ThymeCIK 0001866132Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 27, 2026Common StockMOption exerciseAcquired+233–F1–54,760Direct
Feb 27, 2026Common StockFTax withholdingDisposed−113$51.71−$5,843.2354,647Direct
Feb 27, 2026Common StockMOption exerciseAcquired+329–F1–54,976Direct
Feb 27, 2026Common StockFTax withholdingDisposed−160$51.71−$8,273.654,816Direct
Feb 27, 2026Common StockMOption exerciseAcquired+774–F1–55,590Direct
Feb 27, 2026Common StockFTax withholdingDisposed−375$51.71−$19,391.2555,215Direct
Feb 27, 2026Common StockMOption exerciseAcquired+8,663–F1–63,878Direct
Feb 27, 2026Common StockFTax withholdingDisposed−4,189$51.71−$216,613.1959,689Direct
Mar 2, 2026Common StockMOption exerciseAcquired+13,885$30.96+$429,879.673,574Direct
Mar 2, 2026Common StockSSaleDisposed−13,885$52.29−$726,046.6559,689Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 27, 2026Common StockMOption exerciseDisposed−233$0.00$00Direct
Feb 27, 2026Common StockMOption exerciseDisposed−329$0.00$01,315Direct
Feb 27, 2026Common StockMOption exerciseDisposed−774$0.00$06,189Direct
Feb 27, 2026Common StockMOption exerciseDisposed−8,663$0.00$025,992Direct
Mar 1, 2026Common StockAGrant or awardAcquired+29,275$0.00$029,275Direct
Mar 1, 2026Common StockAGrant or awardAcquired+38,553$0.00$038,553Direct
Mar 2, 2026Common StockMOption exerciseDisposed−13,885$0.00$041,658Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units convert into common stock on a one-for-one basis.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)